Urological cancer, Malmö
261 – 270 of 563
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Reply: A Common Mistake in Assessing the Diagnostic Value of a Test: Failure to Account for Statistical and Methodologic Issues
- Contribution to journal › Letter
-
Mark
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden
- Contribution to journal › Article
-
Mark
Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting
- Contribution to journal › Article
-
Mark
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer
- Contribution to journal › Article
-
Mark
Podocalyxin-like and rna-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer : A validatory study
- Contribution to journal › Article
-
Mark
Expert consensus document : Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure
- Contribution to journal › Scientific review
-
Mark
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- Contribution to journal › Article
-
Mark
Automated evaluation of normal uptake in different skeletal parts in 18F-sodium fluoride (NaF) PET/CT using a new convolutional neural network method
- Contribution to conference › Abstract
- 2016
-
Mark
Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
- Contribution to journal › Article
-
Mark
Radioimmunotherapy for Prostate Cancer-Current Status and Future Possibilities.
- Contribution to journal › Scientific review
